Human endogenous retroviruses in neurologic disease

APMIS

Volumn 124, Issue 1-2, 2016, Pages 116-126

  Christensen, Tove ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Antiretroviral; Epigenetic; Human endogenous retroviruses; Human immunodeficiency viruses; Multiple sclerosis; Neurologic; Schizophrenia

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS ENVELOPE PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ENDOGENOUS RETROVIRUS; ENVELOPE GENE; EPIGENETICS; FAMILY; GENE ACTIVATION; GENE EXPRESSION; GENE PRODUCT; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROLOGY; NEUROPATHOLOGY; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RETROVIRUS INFECTION; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; TREATMENT INDICATION; GENE EXPRESSION REGULATION; GENETICS; HIV INFECTIONS; NERVOUS SYSTEM DISEASES; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

ANTI-RETROVIRAL AGENTS; ENDOGENOUS RETROVIRUSES; EPIGENOMICS; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HUMANS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; SCHIZOPHRENIA; VIRAL ENVELOPE PROTEINS; VIRUS ACTIVATION;

EID: 84969410014     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12486     Document Type: Review

References (127)

1. Ogilvie LA, Bowler LD, Caplin J, Dedi C, Diston D, Cheek E, et al. Genome signature-based dissection of human gut metagenomes to extract subliminal viral sequences. Nat Commun 2013;4:2420.
2. Kernbauer E, Ding Y, Cadwell K. An enteric virus can replace the beneficial function of commensal bacteria. Nature 2014;516:94-8.
3. Yolken RH, Jones-Brando L, Dunigan DD, Kannan G, Dickerson F, Severance E, et al. Chlorovirus ATCV-1 is part of the human oropharyngeal virome and is associated with changes in cognitive functions in humans and mice. Proc Natl Acad Sci USA 2014;111:16106-11.
4. Griffiths DJ. Endogenous retroviruses in the human genome sequence. Genome Biol 2001;2:Reviews1017.
5. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005;15:179-211.
6. Christensen T. HERVs in neuropathogenesis. J Neuroimmune Pharmacol 2010;5:326-35.
7. Villesen P, Aagaard L, Wiuf C, Pedersen FS. Identification of endogenous retroviral reading frames in the human genome. Retrovirology 2004;1:32.
8. Boeke JD, Stoye JP. Retrotransposons, endogenous retroviruses, and the evolution of retroelements. In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 1997:343-435.
9. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
10. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-3.
11. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.
12. Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983;220:865-7.
13. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey MA, Santos-Ferreira MO, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986;233:343-6.
14. Martin MA, Bryan T, Rasheed S, Khan AS. Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci USA 1981;78:4892-6.
15. Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, et al. Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy. AIDS Res Hum Retroviruses 2015;31:242-9.
16. Weiss RA. On the concept and elucidation of endogenous retroviruses. Philos Trans R Soc Lond B Biol Sci 2013;368:20120494.
17. Weiss RA, Stoye JP. Virology. Our viral inheritance. Science 2013;340:820-1.
18. Denner J. HIV infection en route to endogenization: two cases. Clin Microbiol Infect 2014;21:e33-4.
19. Lavignon M, Evans L. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference. J Virol 1996;70:3852-62.
20. Roy-Burman P. Endogenous env elements: partners in generation of pathogenic feline leukemia viruses. Virus Genes 1995;11:147-61.
21. Denner J, Young PR. Koala retroviruses: characterization and impact on the life of koalas. Retrovirology 2013;10:108.
22. Hohn O, Hanke K, Bannert N. HERV-K(HML-2), the best preserved family of HERVs: endogenization, expression, and implications in health and disease. Frontiers Oncol 2013;3:246.
23. Magiorkinis G, Belshaw R, Katzourakis A. 'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era. Philos Trans R Soc Lond B Biol Sci 2013;368:20120504.
24. Douville RN, Nath A. Human endogenous retroviruses and the nervous system. Handb Clin Neurol 2014;123:465-85.
25. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000;403:785-9.
26. Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, et al. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA 2007;104:20534-9.
27. Kassiotis G. Endogenous retroviruses and the development of cancer. J Immunol 2014;192:1343-9.
28. Romanish MT, Cohen CJ, Mager DL. Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol 2010;20:246-53.
29. Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun 2004;4:2.
30. Tonjes RR, Lower R, Boller K, Denner J, Hasenmaier B, Kirsch H, et al. HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl 1):S261-7.
31. Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol 2014;15:415-22.
32. Tugnet N, Rylance P, Roden D, Trela M, Nelson P. Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: is there a link? Open Rheumatol J 2013;7:13-21.
33. Lee-Kirsch MA, Wolf C, Gunther C. Aicardi-Goutieres syndrome: a model disease for systemic autoimmunity. Clin Exp Immunol 2014;175:17-24.
34. Nexo BA, Christensen T, Frederiksen J, Moller-Larsen A, Oturai AB, Villesen P, et al. The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1. PLoS One 2011;6:e16652.
35. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim Biophys Acta 2011;1812:162-76.
36. Moyes DL, Goris A, Ban M, Compston A, Griffiths DJ, Sawcer S, et al. HERV-K113 is not associated with multiple sclerosis in a large family-based study. AIDS Res Hum Retroviruses 2008;24:363-5.
37. Perron H, Firouzi R, Tuke P, Garson JA, Michel M, Beseme F, et al. Cell cultures and associated retroviruses in multiple sclerosis. Acta Neurol Scandinavica Suppl 1997;169:22-31.
38. Christensen T, Jensen AW, Munch M, Haahr S, Sorensen PD, Riemann H, et al. Characterization of retroviruses from patients with multiple sclerosis. Acta Neurol Scand Suppl 1997;169:49-58.
39. Christensen T, Dissing Sorensen P, Riemann H, Hansen HJ, Moller-Larsen A. Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet 1998;352:1033.
40. Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 1998;351:33.
41. Serra C, Sotgiu S, Mameli G, Pugliatti M, Rosati G, Dolei A. Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol Sci 2001;22:171-3.
42. Sotgiu S, Serra C, Mameli G, Pugliatti M, Rosati G, Arru G, et al. Multiple sclerosis-associated retrovirus and MS prognosis: an observational study. Neurology 2002;59:1071-3.
43. Hurst T, Magiorkinis G. Activation of the innate immune response by endogenous retroviruses. J General Virol 2014;96:1207-18.
44. Mameli G, Cossu D, Cocco E, Frau J, Marrosu MG, Niegowska M, et al. Epitopes of HERV-Wenv induce antigen-specific humoral immunity in multiple sclerosis patients. J Neuroimmunol 2015;280:66-8.
45. Brudek T, Christensen T, Hansen HJ, Bobecka J, Moller-Larsen A. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res Hum Retroviruses 2004;20:415-23.
46. Moller-Larsen A, Brudek T, Petersen T, Petersen EL, Aagaard M, Hansen DT, et al. Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells. Clin Exp Immunol 2013;173:398-410.
47. Petersen T, Moller-Larsen A, Thiel S, Brudek T, Hansen TK, Christensen T. Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis. J Neuroimmunol 2009;215:108-16.
48. Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 2001;287:321-32.
49. Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, Moller-Larsen A. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology 2009;6:104.
50. Laska MJ, Brudek T, Nissen KK, Christensen T, Moller-Larsen A, Petersen T, et al. Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol 2012;86:3713-22.
51. Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, et al. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One 2012;7:e44991.
52. Xu Y, Kulkosky J, Acheampong E, Nunnari G, Sullivan J, Pomerantz RJ. HIV-1-mediated apoptosis of neuronal cells: proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc Natl Acad Sci USA 2004;101:7070-5.
53. Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW, et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 2004;7:1088-95.
54. Kremer D, Schichel T, Forster M, Tzekova N, Bernard C, van der Valk P, et al. Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Ann Neurol 2013;74:721-32.
55. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998;4:111-7.
56. Jolivet-Reynaud C, Perron H, Ferrante P, Becquart L, Dalbon P, Mandrand B. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes. Clin Immunol 1999;93:283-93.
57. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001;50:434-42.
58. Antony JM, Zhu Y, Izad M, Warren KG, Vodjgani M, Mallet F, et al. Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis. AIDS Res Hum Retroviruses 2007;23:1251-6.
59. Perron H, Lazarini F, Ruprecht K, Pechoux-Longin C, Seilhean D, Sazdovitch V, et al. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol 2005;11:23-33.
60. Nakamura A, Okazaki Y, Sugimoto J, Oda T, Jinno Y. Human endogenous retroviruses with transcriptional potential in the brain. J Hum Genet 2003;48:575-81.
61. Suntsova M, Gogvadze EV, Salozhin S, Gaifullin N, Eroshkin F, Dmitriev SE, et al. Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH. Proc Natl Acad Sci USA 2013;110:19472-7.
62. Borglum AD, Demontis D, Grove J, Pallesen J, Hollegaard MV, Pedersen CB, et al. Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry 2014;19:325-33.
63. Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M, et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry 2015;20:207-14.
64. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev 2000;31:193-9.
65. Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 2001;98:4634-9.
66. Frank O, Giehl M, Zheng C, Hehlmann R, Leib-Mosch C, Seifarth W. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J Virol 2005;79:10890-901.
67. Huang W, Li S, Hu Y, Yu H, Luo F, Zhang Q, et al. Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophr Bull 2011;37:988-1000.
68. Perron H, Mekaoui L, Bernard C, Veas F, Stefas I, Leboyer M. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol Psychiatry 2008;64:1019-23.
69. Weis S, Llenos IC, Sabunciyan S, Dulay JR, Isler L, Yolken R, et al. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. J Neural Transm (Vienna) 2007;114:645-55.
70. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:616-30.
71. Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, et al. Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. J Med Virol 2000;61:527-32.
72. McCormick AL, Brown RH Jr, Cudkowicz ME, Al-Chalabi A, Garson JA. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 2008;70:278-83.
73. Oluwole SO, Yao Y, Conradi S, Kristensson K, Karlsson H. Elevated levels of transcripts encoding a human retroviral envelope protein (syncytin) in muscles from patients with motor neuron disease. Amyotroph Lateral Scler 2007;8:67-72.
74. Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol 2011;69:141-51.
75. Alfahad T, Nath A. Retroviruses and amyotrophic lateral sclerosis. Antiviral Res 2013;99:180-7.
76. Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med 2015;7:307ra153.
77. Michaels J, Sharer LR, Epstein LG. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodef Rev 1988;1:71-104.
78. Grill MF, Price RW. Central nervous system HIV-1 infection. Handb Clin Neurol 2014;123:487-505.
79. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 2002;202:13-23.
80. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007;3:e165.
81. Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, et al. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. J Clin Investig 2012;122:4473-89.
82. Christensen T. Human herpesviruses in MS. Int MS J 2007;14:41-7.
83. Hollsberg P, Kusk M, Bech E, Hansen HJ, Jakobsen J, Haahr S. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity. Acta Neurol Scand 2005;112:395-402.
84. Haahr S, Hollsberg P. Multiple sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol 2006;16:297-310.
85. Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009;73:32-8.
86. Fotheringham J, Jacobson S. Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease. Herpes 2005;12:4-9.
87. Yao K, Gagnon S, Akhyani N, Williams E, Fotheringham J, Frohman E, et al. Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. PLoS One 2008;3:e2028.
88. Bech E, Lycke J, Gadeberg P, Hansen HJ, Malmestrom C, Andersen O, et al. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 2002;58:31-6.
89. Carter CJ. Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders. Pathog Dis 2013;69:240-61.
90. Csoma E, Bacsi A, Liu X, Szabo J, Ebbesen P, Beck Z, et al. Human herpesvirus 6 variant a infects human term syncytiotrophoblasts in vitro and induces replication of human immunodeficiency virus type 1 in dually infected cells. J Med Virol 2002;67:67-87.
91. Griffiths PD. Herpesviruses and AIDS. Scand J Infect Dis Suppl 1996;100:3-7.
92. Perron H, Suh M, Lalande B, Gratacap B, Laurent A, Stoebner P, et al. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J General Virol 1993;74:65-72.
93. Sutkowski N, Chen G, Calderon G, Huber BT. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol 2004;78:7852-60.
94. Turcanova VL, Bundgaard B, Hollsberg P. Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen. J Clin Virol 2009;46:15-9.
95. Goff SP. Retrovirus restriction factors. Mol Cell 2004;16:849-59.
96. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005;3:799-808.
97. Teich NM, Weiss RA, Martin GR, Lowy DR. Virus infection of murine teratocarcinoma stem cell lines. Cell 1977;12:973-82.
98. Wolf D, Hug K, Goff SP. TRIM28 mediates primer binding site-targeted silencing of Lys 1, 2 tRNA-utilizing retroviruses in embryonic cells. Proc Natl Acad Sci USA 2008;105:12521-6.
99. Fasching L, Kapopoulou A, Sachdeva R, Petri R, Jonsson ME, Manne C, et al. TRIM28 represses transcription of endogenous retroviruses in neural progenitor cells. Cell Rep 2015;10:20-8.
100. Sweatt JD. The emerging field of neuroepigenetics. Neuron 2013;80:624-32.
101. Santoni FA, Guerra J, Luban J. HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency. Retrovirology 2012;9:111.
102. Nexo BA, Hansen B, Nissen KK, Gundestrup L, Terkelsen T, Villesen P, et al. Restriction genes for retroviruses influence the risk of multiple sclerosis. PLoS One 2013;8:e74063.
103. Sharma P, Azebi S, England P, Christensen T, Moller-Larsen A, Petersen T, et al. Citrullination of histone H3 interferes with HP1-mediated transcriptional repression. PLoS Genet 2012;8:e1002934.
104. Oh U, Yamano Y, Mora CA, Ohayon J, Bagnato F, Butman JA, et al. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease. Ann Neurol 2005;57:526-34.
105. Brule F, Khatissian E, Benani A, Bodeux A, Montagnier L, Piette J, et al. Inhibition of HIV replication: a powerful antiviral strategy by IFN-beta gene delivery in CD4 + cells. Biochem Pharmacol 2007;74:898-910.
106. Mameli G, Serra C, Astone V, Castellazzi M, Poddighe L, Fainardi E, et al. Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol 2008;14:73-7.
107. Petersen T, Moller-Larsen A, Ellermann-Eriksen S, Thiel S, Christensen T. Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis. J Neuroimmunol 2012;249:105-8.
108. Maruszak H, Brew BJ, Giovannoni G, Gold J. Could antiretroviral drugs be effective in multiple sclerosis? A case report. Eur J Neurol 2011;18:e110-1.
109. Nexo BA, Pedersen L, Sorensen HT, Koch-Henriksen N. Treatment of HIV and risk of multiple sclerosis. Epidemiology 2013;24:331-2.
110. Gold J, Goldacre R, Maruszak H, Giovannoni G, Yeates D, Goldacre M. HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J Neurol Neurosurg Psychiatry 2015;86:9-12.
111. Chin JH. Multiple sclerosis and HIV-1 infection: case report of a HIV controller. J Neurovirol 2015;21:464-7.
112. Kremer D, Forster M, Schichel T, Gottle P, Hartung HP, Perron H, et al. The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade. Mult Scler 2014;21:1200-3.
113. Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, et al. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. Mult Scler 2015;21:885-93.
114. Blank MB, Himelhoch S, Walkup J, Eisenberg MM. Treatment considerations for HIV-infected individuals with severe mental illness. Curr HIV/AIDS Rep 2013;10:371-9.
115. Hoffman PM, Festoff BW, Giron LT Jr, Hollenbeck LC, Garruto RM, Ruscetti FW. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. New Engl J Med 1985;313:324-5.
116. Sinha S, Mathews T, Arunodaya GR, Siddappa NB, Ranga U, Desai A, et al. HIV-1 clade-C-associated "ALS"-like disorder: first report from India. J Neurol Sci 2004;224:97-100.
117. Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci 2006;240:59-64.
118. Silva K, Hope-Lucas C, White T, Hairston TK, Rameau T, Brown A. Cortical neurons are a prominent source of the proinflammatory cytokine osteopontin in HIV-associated neurocognitive disorders. J Neurovirol 2015;21:174-85.
119. McArthur JC, Steiner J, Sacktor N, Nath A. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 2010;67:699-714.
120. Bhat RK, Rudnick W, Antony JM, Maingat F, Ellestad KK, Wheatley BM, et al. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS. PLoS One 2014;9:e97984.
121. Giovannoni G, Cutter GR, Lunemann J, Martin R, Munz C, Sriram S, et al. Infectious causes of multiple sclerosis. Lancet Neurol 2006;5:887-94.
122. Christensen T, Giovannoni G. HERVs: have we been here before? Mult Scler 2013;19:827-9.
123. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 1997;94:7583-8.
124. Laufer G, Mayer J, Mueller BF, Mueller-Lantzsch N, Ruprecht K. Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences. Retrovirology 2009;6:37.
125. Belshaw R, Katzourakis A, Paces J, Burt A, Tristem M. High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol 2005;22:814-7.
126. Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, et al. Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy. Virol J 2013;10:360.
127. Jeong BH, Lee YJ, Carp RI, Kim YS. The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt-Jakob disease. J Clin Virol 2010;47:136-42.